source
- MoonLake Immunotherapeutics’ vague data on its autoimmune candidate draws criticismAdam Feuerstein notes that MoonLake Immunotherapeutics announced "positive" results for its autoimmune drug candidate but released data that is difficult to interpret. He reminds readers that biot…
- WuXi AppTec Co-CEO Stresses Need for True Resilience Beyond Redundancy in Biopharma InnovationIn a recent Fierce Biotech interview, WuXi AppTec co-CEO Dr. Steve Yang discussed how the biopharma sector can build resilience as scientific challenges grow. Yang said resilience is not just abou…